Cargando…
CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis
BACKGROUND: Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. As a cell adhesion molecule, poliovirus receptor (PVR/CD155) is abnormally overexpressed in tumour cells, and related to tumour proliferation and invasion. However, the potential role and mechanism of CD155 hav...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982318/ https://www.ncbi.nlm.nih.gov/pubmed/35384345 http://dx.doi.org/10.1002/ctm2.794 |
_version_ | 1784681783666671616 |
---|---|
author | Jin, An‐Li Zhang, Chun‐Yan Zheng, Wen‐Jing Xian, Jing‐Rong Yang, Wen‐Jing Liu, Te Chen, Wei Li, Tong Wang, Bei‐Li Pan, Bai‐Shen Li, Qian Cheng, Jian‐Wen Wang, Peng‐Xiang Hu, Bo Zhou, Jian Fan, Jia Yang, Xin‐Rong Guo, Wei |
author_facet | Jin, An‐Li Zhang, Chun‐Yan Zheng, Wen‐Jing Xian, Jing‐Rong Yang, Wen‐Jing Liu, Te Chen, Wei Li, Tong Wang, Bei‐Li Pan, Bai‐Shen Li, Qian Cheng, Jian‐Wen Wang, Peng‐Xiang Hu, Bo Zhou, Jian Fan, Jia Yang, Xin‐Rong Guo, Wei |
author_sort | Jin, An‐Li |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. As a cell adhesion molecule, poliovirus receptor (PVR/CD155) is abnormally overexpressed in tumour cells, and related to tumour proliferation and invasion. However, the potential role and mechanism of CD155 have not yet been elucidated in HCC. METHODS: Immunohistochemistry, RT‐PCR and Western blot assays were used to determine CD155 expression in HCC cell lines and tissues. Cell Counting Kit‐8 and colony formation assays were used to examine cell proliferation. Transwell and wound healing assays were used to evaluate cell migration and invasion. Cell apoptosis and cycle distribution were assessed by flow cytometry. Cox regression and Kaplan–Meier analyses were performed to explore the clinical significance of CD155. The role of CD155 in vivo was evaluated by establishing liver orthotropic xenograft mice model. RNA sequencing, bioinformatics analysis and co‐immunoprecipitation assay were used to explore the downstream signalling pathway of CD155. RESULTS: CD155 was upregulated in HCC tissues and represented a promising prognostic indicator for HCC patients (n = 189) undergoing curative resection. High CD155 expression enhanced cell proliferation, migration and invasion, and contributed to cell survival in HCC. CD155 overexpression also induced epithelial–mesenchymal transition in HCC cells. CD155 function in HCC involved SRC/p38 MAPK signalling pathway. CD155 interacted with SRC homology‐2 domain of SRC and promoted SRC activation, further inhibiting the downstream p38 MAPK signalling pathway in HCC. CONCLUSIONS: CD155 promotes HCC progression via the SRC/p38 MAPK signalling pathway. CD155 may represent a predictor for poor postsurgery prognosis in HCC patients. |
format | Online Article Text |
id | pubmed-8982318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89823182022-04-11 CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis Jin, An‐Li Zhang, Chun‐Yan Zheng, Wen‐Jing Xian, Jing‐Rong Yang, Wen‐Jing Liu, Te Chen, Wei Li, Tong Wang, Bei‐Li Pan, Bai‐Shen Li, Qian Cheng, Jian‐Wen Wang, Peng‐Xiang Hu, Bo Zhou, Jian Fan, Jia Yang, Xin‐Rong Guo, Wei Clin Transl Med Research Articles BACKGROUND: Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. As a cell adhesion molecule, poliovirus receptor (PVR/CD155) is abnormally overexpressed in tumour cells, and related to tumour proliferation and invasion. However, the potential role and mechanism of CD155 have not yet been elucidated in HCC. METHODS: Immunohistochemistry, RT‐PCR and Western blot assays were used to determine CD155 expression in HCC cell lines and tissues. Cell Counting Kit‐8 and colony formation assays were used to examine cell proliferation. Transwell and wound healing assays were used to evaluate cell migration and invasion. Cell apoptosis and cycle distribution were assessed by flow cytometry. Cox regression and Kaplan–Meier analyses were performed to explore the clinical significance of CD155. The role of CD155 in vivo was evaluated by establishing liver orthotropic xenograft mice model. RNA sequencing, bioinformatics analysis and co‐immunoprecipitation assay were used to explore the downstream signalling pathway of CD155. RESULTS: CD155 was upregulated in HCC tissues and represented a promising prognostic indicator for HCC patients (n = 189) undergoing curative resection. High CD155 expression enhanced cell proliferation, migration and invasion, and contributed to cell survival in HCC. CD155 overexpression also induced epithelial–mesenchymal transition in HCC cells. CD155 function in HCC involved SRC/p38 MAPK signalling pathway. CD155 interacted with SRC homology‐2 domain of SRC and promoted SRC activation, further inhibiting the downstream p38 MAPK signalling pathway in HCC. CONCLUSIONS: CD155 promotes HCC progression via the SRC/p38 MAPK signalling pathway. CD155 may represent a predictor for poor postsurgery prognosis in HCC patients. John Wiley and Sons Inc. 2022-04-05 /pmc/articles/PMC8982318/ /pubmed/35384345 http://dx.doi.org/10.1002/ctm2.794 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Jin, An‐Li Zhang, Chun‐Yan Zheng, Wen‐Jing Xian, Jing‐Rong Yang, Wen‐Jing Liu, Te Chen, Wei Li, Tong Wang, Bei‐Li Pan, Bai‐Shen Li, Qian Cheng, Jian‐Wen Wang, Peng‐Xiang Hu, Bo Zhou, Jian Fan, Jia Yang, Xin‐Rong Guo, Wei CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title | CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title_full | CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title_fullStr | CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title_full_unstemmed | CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title_short | CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis |
title_sort | cd155/src complex promotes hepatocellular carcinoma progression via inhibiting the p38 mapk signalling pathway and correlates with poor prognosis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982318/ https://www.ncbi.nlm.nih.gov/pubmed/35384345 http://dx.doi.org/10.1002/ctm2.794 |
work_keys_str_mv | AT jinanli cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT zhangchunyan cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT zhengwenjing cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT xianjingrong cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT yangwenjing cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT liute cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT chenwei cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT litong cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT wangbeili cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT panbaishen cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT liqian cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT chengjianwen cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT wangpengxiang cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT hubo cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT zhoujian cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT fanjia cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT yangxinrong cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis AT guowei cd155srccomplexpromoteshepatocellularcarcinomaprogressionviainhibitingthep38mapksignallingpathwayandcorrelateswithpoorprognosis |